SecBot SecBot
DEFA14A ·Filed Apr 3, 2026

RIGL

RIGEL PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001034842-26-000024
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine SEC filing with no actionable financial information. Traders should ignore this filing as it does not contain any material information about the company's operations, financials, or strategic direction. Monitor for the release of the full proxy statement for any material information.

DirectionNeutral
Confidencelow
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$27.36
T+0 close · Apr 3, 2026 · via day close
Latest settled
+39.95%
T+60 · $38.29
Vs SPY
+26.48%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 6 $27.36entry
  2. T+1 · 7mo ago +5.01%α +4.94% · $28.73
  3. T+5 · 7mo ago +9.54%α +5.40% · $29.97
  4. T+20 · 7mo ago +7.97%α −1.01% · $29.54
  5. T+60 · 5mo ago +39.95%α +26.48% · $38.29
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RIGEL PHARMACEUTICALS INC filed a Definitive Additional Materials (DEFA14A) form, which is supplementary proxy solicitation material related to a shareholder vote. The documents provided are primarily technical SEC filing headers and do not contain substantive information about the vote, such as what is being voted on, the outcome, or management's position. This is a routine administrative filing.

Key Facts

  • The filing is a DEFA14A, which is Definitive Additional Materials for a proxy statement.
  • The documents provided are technical SEC headers and a graphic, not the substantive proxy statement content.
  • The filing is routine and administrative in nature.
  • No information about the vote, candidates, or issues is available in the provided documents.

Financial Impact

No financial impact information available.

Risk Factors

  • The provided documents are incomplete and do not contain the actual proxy statement content.
  • There is a risk of misinterpreting this routine filing as a material event.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001034842-26-000024
Document: 0001034842-26-000024-index-headers.html0001034842-26-000024
Document: 0001034842-26-000024-index.html0001034842-26-000024
Document: 0001034842-26-000024.txt0001034842-26-000024

Track record

12 reports on RIGL

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.02% at T+60 after the May 12, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $45.03 Now $43.73 −2.89% settles Feb 12
  2. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $44.21 Now $43.73 −1.09% settles Feb 12
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $43.91 Now $43.73 −0.41% settles Feb 8
  4. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $39.65 Now $43.73 −10.29% settles Feb 4
  5. Aug 4, 202614w ago 8-K Mixed 6/10 Entry $40.48 to $50.92 Now $43.73 +8.03% ▲ +25.79% +25.60% vs SPY
  6. Jun 17, 202621w ago 8-K Neutral 4/10 Entry $32.91 to $45.35 Now $43.73 +32.88% ▲ +37.80% +35.91% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $32.08 to $48.67 Now $43.73 +36.32% ▲ +51.71% +47.32% vs SPY
  8. May 20, 202625w ago 8-K Neutral 2/10 Entry $29.19 to $42.45 Now $43.73 +49.81% ▲ +45.43% +41.13% vs SPY
  9. May 12, 202626w ago 8-K Bullish 7/10 Entry $32.13 to $40.17 Now $43.73 +36.10% ▲ +25.02% +20.59% vs SPY
  10. May 5, 202627w ago 8-K Bearish 7/10 Entry $26.67 to $36.81 Now $43.73 −63.97% ▼ −38.02% −35.96% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026